FDA announces Atorvastatin recall affecting over 140,000 bottles of cholesterol medication due to failed dissolution specs ...
FDA approves Bayer’s Lynkuet, a first-of-its-kind non-hormonal pill to treat moderate to severe menopausal hot flashes by ...
The U.S. Food and Drug Administration has approved Bayer's drug to ease hot flashes in menopausal women, the German company ...
The U.S. Food and Drug Administration (FDA) announced that it will fast-track review of nine experimental drugs.
The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday.
The winners include a gene therapy for a rare form of deafness, a drug for vaping addiction, and a generic antibiotic.
The Food and Drug Administration has announced a recall for several brands of cat and dog food associated with parent company ...
CLOVER-2 Phase 1 Clinical Study Evaluating Iopofosine I 131 in Relapsed/Refractory Pediatric High-Grade Glioma Patients Showed Extended Progression Free Survival and Overall Survival ...
The Food and Drug Administration granted orphan drug designation to Revolution Medicines' treatment for pancreatic cancer. The drug, called daraxonrasib, is being studied in a global phase three ...
Amid the chaos of the Trump administration’s haphazard job cuts and a mass exodus of leadership, the Food and Drug ...
GSK's London-listed shares fell about 2% on Friday after the U.S. Food and Drug Administration approved only one of two ...
Bayer AG won support from US regulators for a menopause drug that’s expected to hit the market in November under the name of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback